WYZAFRI

Glaxo Group Limited

Application Filed: 2019-04-24
Trademark Application Details
Trademark Logo WYZAFRI

Mark For: WYZAFRI™ trademark registration is intended to cover the categories of pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines. [all]

Status

2020-05-27 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88399914
Mark Literal ElementsWYZAFRI
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2019-10-08
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameMerilee J. Arevalo
Attorney Docket Number82774771
Law Office AssignedL80
Employee NameHACK, ANDREA R

Timeline

2019-04-24Application Filed
2019-08-13Published
2019-08-13Published for Opposition
2019-10-08Location: INTENT TO USE SECTION
2019-10-08Status: Live/Pending
2019-10-08Transaction Date
2020-02-10Status: A first request for extension of time to file a Statement of Use has been granted.

Trademark Parties (Applicants & Owners)

Party: Glaxo Group Limited
Address980 Great West Road Brentford, Middlesex UNITED KINGDOM TW89GS
Legal Entity TypePrivate Company Limited By Shares (prc)
Legal Entity StateENGLAND

Attorney of Record

MERILEE J. AREVALO
GSK
5 MOORE DRIVE
LBP, 5.5A
RESEARCH TRIANGLE PARK, NC 27709-3398

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Filing History

DescriptionDateProceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-02-12
TEAS EXTENSION RECEIVED2020-02-10
EXTENSION 1 GRANTED2020-02-1098765
EXTENSION 1 FILED2020-02-1098765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2019-10-08
PUBLISHED FOR OPPOSITION2019-08-13
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-08-13
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-07-24
APPROVED FOR PUB - PRINCIPAL REGISTER2019-07-08
ASSIGNED TO EXAMINER2019-07-0483187
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2019-05-09
NEW APPLICATION ENTERED IN TRAM2019-04-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed